Premium
What is new on molecular characteristics of Avian metapneumovirus strains circulating in Europe?
Author(s) -
Mescolini Giulia,
Lupini Caterina,
Franzo Giovanni,
Quaglia Giulia,
Legnardi Matteo,
Cecchinato Mattia,
Tucciarone Claudia M.,
Blanco Angela,
Turblin Vincent,
Biarnés Mar,
Tatone Fabrizio,
Falchieri Marco,
Catelli Elena
Publication year - 2021
Publication title -
transboundary and emerging diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.392
H-Index - 63
eISSN - 1865-1682
pISSN - 1865-1674
DOI - 10.1111/tbed.13788
Subject(s) - phylogenetic tree , metapneumovirus , biology , genbank , virology , clade , human metapneumovirus , phylogenetics , molecular epidemiology , virus , sequence analysis , genetics , gene , genotype , respiratory tract infections , anatomy , respiratory system
In the present study, one hundred and sixteen partial G gene sequences of Avian metapneumovirus (aMPV) subtype B, obtained during routine diagnostics in different European Countries in the last few years (2014–2019), were analysed by sequence and phylogenetic analyses in order to draw an updated picture of the molecular characteristics of circulating strains. Nucleotide sequences were compared with other sequences of European and non‐European aMPV‐Bs collected prior to that period or retrieved from GenBank. Phylogenetic relationships among the aMPV‐B strains, reconstructed using the maximum likelihood method implemented in MEGA X, demonstrated that aMPV‐B has evolved in Europe from its first appearance, frequently displaying a clear relation with the geographic area of detection. The 40% of aMPV‐B viruses analysed were classified as vaccine‐derived strains, being phylogenetically related, and showing high nucleotide identity with live commercial vaccine strains licensed in Europe. The remaining 60% were classified as field strains since they clustered separately and showed a low nucleotide identity with vaccines and vaccine‐derived strains. The phylogenetic tree showed that the virus has continued to evolve from its first appearance in the ’80s since more recently detected strains belonged to clades phylogenetically distant from the older strains. Unlike vaccine‐derived strains, field strains tended to cluster according to their geographic origin and irrespective of the host species where the viruses had been detected. In conclusion, the molecular characterization of aMPV‐B and the differentiation between vaccines and field strains through G gene sequence analysis can be a useful tool towards correct diagnosis and should be routinely applied in order to better address the control strategies.